Connect Biopharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Connect Biopharma Stock Summary

Connect Biopharma competes with Assembly Biosciences, Instil Bio, CytomX Therapeutics, Achilles Therapeutics, and NextCure. Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company was founded in 2012 and is headquartered in Taicang, China. Connect Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 108 people.

Connect Biopharma Key Financial Ratios

Connect Biopharma Key Balance Sheet Accounts

Connect Biopharma Key Income Statement Accounts

Connect Biopharma Key Cash Accounts

Connect Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Connect Biopharma's current stock value. Our valuation model uses many indicators to compare Connect Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Connect Biopharma competition to find correlations between indicators driving Connect Biopharma's intrinsic value. More Info.Connect Biopharma Holdings is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers . At present, Connect Biopharma's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Connect Biopharma's earnings, one of the primary drivers of an investment's value.

Connect Biopharma Systematic Risk

Today, most investors in Connect Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Connect Biopharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Connect Biopharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Connect Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Connect Biopharma Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Connect Biopharma Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Connect Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Connect Biopharma's daily price indicators and compare them against related drivers.

When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.